Background: Rhinitis is characterized clinical by chronic runny nose, sneezing, nasal itching, congestion and postnasal discharge, among other symptoms. It s classified as allergic and non allergic. Skin prick testing is the principal diagnosis method for allergic rhinits. However, there is a group of patients with chronic rhinopathy that have negative skin tests, the objective of this study was to determine the cutaneous response to patch tests with Dermatophagoides farinae and Dermatophagoides pteronyssinus in patients with chronic rhinitis. Methods: It was a cross-sectional, observational and descriptive study. We included patients over 18 years old. They were divided into 3 groups; Group A patients who came for the first time with a history of chronic rhinopathy over 18 months of evolution and positive skin tests for aeroallergens; group B patients with chronic rhinitis with at least one year of evolution and negative skin tests; group C healthy volunteers. Patch test with farinae and pteronisyinnus were done in the subjects of all 3 groups, with readings at 48 and 72 hours. Results: A total of 37 patients were studied, mean age 26.1 years. Twenty two were male subjects (60%). The mean lenghtof chronic rhinophaty was 10.8 years. Six patients had positive patch test to any of the mites tested; 2 (33%) in group A, 2 (33%) in group B and 2 (33%) of the control group, but it was not statistically significant (P . 0.05). Conclusions: Although the results were not statistically significant, there were patients with chronic rhinitis wich had positive patch test for mites. This sensitization could be clinically significant for those patients. Instituto Dermopatico dell'Immacolata, Rome, Italy. Background: Microarray technique is promising in allergy diagnosis. The aim of this study was to compare SPT with specific-IgE by microarray in a group of patients with rhinitis. Methods: Cross-sectional study, 101 participants with rhinitis diagnosed according to ARIA (89.1% with asthma); age range 6 to 15 years. SPT was done with Dermatophagoides pteronyssinus (Dp), Blattella germanica (Bg), cat and dog allergenic extracts (IPI ASAC Brasil); a mean wheal diameter of $2 mm greater than the negative control was considered positive. Sera were analysed for allergen specific IgE antibodies to Dp (Der p 1, Der p 2), Bg (Bla g 1, Bla g 2, Bla g 4, Bla g 5), cat (Fel d 1, Fel d 2) and dog (Can f 1, Can f 2) allergens using a microarray system (ImmunoCAP ISAC, PMD, Austria), considered positive $0.3 ISU (ISAC standardized units). Categorical variables were shown as percentage and differences between the 2 methods verified by chi-square test; P , 0.05 was considered significant. Results: SPT was positive to Dp in 88.1% whereas ISAC was positive to Der p 1 in 74.2% (P , 0.001) and Der p 2 in 73.3% (P , 0.01) respectively. Sensitivity of SPT was 97% and specificity was 38%. The remaining allergens caused less SPT reactions (cockroach 25.7%, cat 22.8%, dog 27.7%) and these were associated with lower detection of specific-IgE by ISAC respectively Bla g 1 (0.9%, P ¼ 0.09), Bla g 2 (0%), Bla g 4 (0%), Bla g 5 (0.9%, P ¼ 0.55); Fel d 1 (16.8%, P , 0.01), Fel d 2 (0.9%, P ¼ 0.06); Can f 1 (4.9%, P ¼ 0.53), Can f 2 (2.9%, P , 0.001). Conclusions: SPT remains the favored method to detect IgE-mediated sensitivity to aeroallergens. SPT was highly sensitive for Dp though less specific in comparison with the IgE microarray to Der p 1 and Der p 2 allergens. 5 Otorrinolaringologia, Sanatorio Allende, Córdoba, Argentina. Background: A high percentage of patients with moderate-severe persistent allergic rhinitis (PAR) also show symptoms related to impaired smell (21-23%).Olfactory dysfunction can have a significant impact on quality of life (QoL) in these patients. The high frequency of this subjective condition not always reflect the magnitude of the problem experienced by PAR-patients in real life and usually goes unnoticed. The aim of this study was to assess the olfactory dysfunction in patients with PAR and seek the association with the PAR-severity, sleep disturbance and QoL. Methods: We studied 50 patients with physician-diagnosed PAR consulting a tertiary medical centre, 33 (66%) were female and 17 (34%) male. Mean age 43 years old, compared with 20 healthy volunteers. Clinical history and assessment of severity based on ARIA criteria, skin prick tests with mite mix, mould and pollens, QoL questionnaire for allergic rhino-conjuntivitis (Juniper RQLQ) were done. In addition the Epworth Sleepiness Scale (ESS) and the Connecticut smell test (CST) were performed in every patient. Results: In patients with PAR, 30% had mild PAR and 70% the moderate/ severe form.48% of the patients studied had abnormalities of smell. We found an alteration of smell in 18% of mild-PAR and 60% in the severe/moderate patients (P , .006).There was no statistically significant relationship between olfactory impairment and sleep disturbance with the ESS (P , .85), nor in the alteration of smell in patients with polyps detected at physical examination (P , .57) or the relationship between impaired smell and smoking (P , .36).Patients with moderate/severe PAR also had alterations in QoL. Nasal obstruction was the most important parameter (70%) associated with the QoL worsening. Conclusions: This study shows the impact of PAR on the olfactory dysfunction. An association between smell impairment and the severity of nasal symptoms was found. Smell impairment plays an important role in worsening QoL. CST is a tool that could be used in patients with PAR.
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